Addendum to the National Consensus on the Management of Dyspepsia and Helicobacter Pylori Infection in Indonesia 2024
Based on the latest scientific data, there is a new pharmacological therapy available in Indonesia for the management of Helicobacter pylori infection: Vonoprazan. Vonoprazan is a novel Potassium-Competitive Acid Blocker (P-CAB) that can replace the role of Proton …
Masterclass Inflammatory Bowel Disease (IBD): Meet and Practice from the Expert
The Central Board of the Indonesian Gastroenterology Association (PB PGI) held the “Masterclass Inflammatory Bowel Disease (IBD): Meet and Practice from the Expert” on February 4, 2024, at the Double Tree Hotel, Jakarta.
This event brought together 22 gastroenterology …
First Plenary Meeting of the Indonesian Gastroenterology Association (PB PGI)
Adendum Konsensus Nasional Penatalaksanaan Konstipasi di Indonesia Tahun 2023
Currently, there is a new pharmacological modality for chronic constipation available in Indonesia: Elobixibat. Elobixibat is a bile acid transporter inhibitor that works by inhibiting the reabsorption of bile salts in enterocytes in the ileum, so that the residual …
Indonesia Inflammatory Bowel Disease (IBD) Masterclass 2023
The Central Board of the Indonesian Gastroenterology Association (PB PGI) held the “Indonesia Inflammatory Bowel Disease (IBD) Masterclass 2023” on December 3, 2023. The event was conducted in a hybrid format at the Westin Hotel, Jakarta, and via Zoom …
